The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.
Conditions
- Diffuse Large B-cell Lymphoma
Interventions
- DRUG: Mitoxantrone hydrochloride liposome injection
- DRUG: RiTUXimab Injection
- DRUG: Cyclophosphamid
- DRUG: Vincristine
- DRUG: Prednisolone
Sponsor
The First Hospital of Jilin University
Collaborators